{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T09:06:10Z","timestamp":1742807170247,"version":"3.37.3"},"reference-count":193,"publisher":"Informa UK Limited","issue":"5-6","funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["International Review of Psychiatry"],"published-print":{"date-parts":[[2023,8,18]]},"DOI":"10.1080\/09540261.2023.2249084","type":"journal-article","created":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T15:07:20Z","timestamp":1693926440000},"page":"397-417","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Psychopharmacology of smoking cessation medications: focus on patients with mental health disorders"],"prefix":"10.1080","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9621-2291","authenticated-orcid":false,"given":"Jo\u00e3o Mauricio","family":"Castaldelli-Maia","sequence":"first","affiliation":[{"name":"Cellule de Recherche Clinique, Groupe Hospitalier du Havre, Le Havre, France"},{"name":"Department of Psychiatry, Medical School, University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Camargos de Oliveira","sequence":"additional","affiliation":[{"name":"Hospital Municipal Prof. Dr. Al\u00edpio Corr\u00eaa Neto, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fl\u00e1via Mariana","family":"Irber","sequence":"additional","affiliation":[{"name":"Hospital Municipal Prof. Dr. Al\u00edpio Corr\u00eaa Neto, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Israel K.","family":"Blaas","sequence":"additional","affiliation":[{"name":"Perdizes Institute (IPer), Clinics Hospital (HCFMUSP), Medical School, University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Angerville","sequence":"additional","affiliation":[{"name":"\u00c9tablissement Public de Sant\u00e9 Barth\u00e9l\u00e9my Durand, \u00c9tampes, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anderson","family":"Sousa Martins-da-Silva","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Medical School, University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gislaine","family":"Koch Gimenes","sequence":"additional","affiliation":[{"name":"Perdizes Institute (IPer), Clinics Hospital (HCFMUSP), Medical School, University of S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela","family":"Waisman Campos","sequence":"additional","affiliation":[{"name":"Department of Cognitive Neurology, Neuropsychiatry, and Neuropsychology, FLENI, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"Torales","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, National University of Asuncion, San Lorenzo, Paraguay"},{"name":"Regional Institute of Health Research, Universidad Nacional de Caaguaz\u00fa, Coronel Oviedo, Paraguay"},{"name":"School of Health Sciences, Universidad Sudamericana, Pedro Juan Caballero, Paraguay"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Ventriglio","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carine","family":"Guillois","sequence":"additional","affiliation":[{"name":"Cellule de Recherche Clinique, Groupe Hospitalier du Havre, Le Havre, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1021-7134","authenticated-orcid":false,"given":"Houria","family":"El Ouazzani","sequence":"additional","affiliation":[{"name":"Cellule de Recherche Clinique, Groupe Hospitalier du Havre, Le Havre, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e9na","family":"Gazaix","sequence":"additional","affiliation":[{"name":"Cellule de Recherche Clinique, Groupe Hospitalier du Havre, Le Havre, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Favr\u00e9","sequence":"additional","affiliation":[{"name":"\u00c9tablissement Public de Sant\u00e9 Mentale, Neuilly sur Marne, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5957-8948","authenticated-orcid":false,"given":"Alain","family":"Dervaux","sequence":"additional","affiliation":[{"name":"\u00c9tablissement Public de Sant\u00e9 Barth\u00e9l\u00e9my Durand, \u00c9tampes, France"},{"name":"Universit\u00e9 Paris-Saclay, Le Kremlin-Bic\u00eatre, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gis\u00e8le","family":"Apter","sequence":"additional","affiliation":[{"name":"Cellule de Recherche Clinique, Groupe Hospitalier du Havre, Le Havre, France"},{"name":"Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy"},{"name":"\u00c9tablissement Public de Sant\u00e9 Mentale, Neuilly sur Marne, France"},{"name":"Societ\u00e9 de l\u2019Information Psychiatrique, Bron, France"},{"name":"University of Rouen Normandy, Rouen, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,9,5]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1590\/1516-4446-2012-0907"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200115060-00004"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199936060-00004"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/14622200500185298"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200210000-00007"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198814050-00002"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.crd.0000172309.06270.25"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.24.3244"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-849X.2012.00906.x"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30272-0"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-019-04858-2"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161211796150837"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.16lr10669"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2011.06.007"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39545.852616.BE"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/da.22982"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntq215"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2016.1197203"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.15440"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.48.113006.094742"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-105443"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100358"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174465"},{"key":"e_1_3_2_25_1","unstructured":"BoehringerIngelheim. (1998). Catapres (clonidine hydrochloride USP) [prescribing information]. BoehringerIngelheim."},{"issue":"2","key":"e_1_3_2_26_1","first-page":"153","article-title":"Efficacy of transdermalclonidine for headacheprophylaxis and reduction of narcotic use in migraine patients. A randomizedcrossover trial","volume":"29","author":"Bredfeldt R. C.","year":"1989","unstructured":"Bredfeldt, R. C., Sutherland, J. E., & Kruse, J. E. (1989). Efficacy of transdermalclonidine for headacheprophylaxis and reduction of narcotic use in migraine patients. A randomizedcrossover trial. J Fam Pract, 29(2), 153\u2013156.","journal-title":"J Fam Pract,"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-010-1970-0"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270006291837"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006103.pub7"},{"issue":"5","key":"e_1_3_2_30_1","first-page":"CD009329","article-title":"Pharmacological interventions for smoking cessation: an overview and network meta-analysis","volume":"2013","author":"Cahill K.","year":"2013","unstructured":"Cahill, K., Stevens, S., Perera, R., & Lancaster, T. (2013). Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev, 2013(5), CD009329.","journal-title":"Cochrane Database Syst Rev,"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.3109\/09540261.2014.928272"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2018.02.005"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2011.01.001"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.13m08756"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm050069n"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntab056"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.122.2.403"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1080\/03602532.2019.1620763"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2020.03.071"},{"issue":"5","key":"e_1_3_2_40_1","article-title":"Varenicline for smoking cessation","volume":"96","author":"Crawford P.","year":"2017","unstructured":"Crawford, P., & Cieslak, D. (2017). Varenicline for smoking cessation. American Family Physician, 96(5).","journal-title":"American Family Physician"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1177\/070674370404900209"},{"key":"e_1_3_2_42_1","volume-title":"Amitriptyline Therapy and CYP2D6 and CYP2C19 Genotype. Medical Genetics Summaries","author":"Dean L.","year":"2012","unstructured":"Dean, L. (2012). Amitriptyline Therapy and CYP2D6 and CYP2C19 Genotype. Medical Genetics Summaries. National Center for Biotechnology Information."},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)02158-8"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2004.02.011"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200115060-00005"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_313_20"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v59n0705"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2020.10.046"},{"issue":"1","key":"e_1_3_2_49_1","first-page":"23","article-title":"Clonidine (Dixarit) for menopausal flushing","volume":"123","author":"Edington R. F.","year":"1980","unstructured":"Edington, R. F., Chagnon, J. P., & Steinberg, W. M. (1980). Clonidine (Dixarit) for menopausal flushing. Canadian Medical Association Journal. 123(1), 23\u201326.","journal-title":"Canadian Medical Association Journal"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1517\/14728214.2014.899580"},{"key":"e_1_3_2_51_1","unstructured":"European Medicines Agency. (n.d.). Champix: summary of product characteristics [online]. http:\/\/www.ema.europa.eu\/docs\/en_GB\/doc ument_library\/EPAR_-_Product_Information\/human\/000699\/WC500025251.pdf"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001015"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1097\/HRP.0000000000000063"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.202000032"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2004.04.003"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270006292624"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.2165\/11537850-000000000-00000"},{"issue":"10","key":"e_1_3_2_58_1","first-page":"1222","article-title":"Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity","volume":"28","author":"Faucette S. R.","year":"2000","unstructured":"Faucette, S. R., Hawke, R. L., Lecluyse, E. L., Shord, S. S., Yan, B., Laethem, R. M., & Lindley, C. M. (2000). Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity. Drug Metabolism and Disposition: The Biological Fate of Chemicals, 28(10), 1222\u20131230.","journal-title":"Drug Metabolism and Disposition: The Biological Fate of Chemicals"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.v07n0305"},{"key":"e_1_3_2_60_1","unstructured":"FDA. (2016). Varenicline (marketedaschantix) information. https:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationfor PatientsandProviders\/ucm106540.htm"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2011.02.002"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00637513"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1586\/14737175.6.9.1249"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.262.21.3011"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.20.19.1423.34854"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2009.03.021"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30752-2"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1985.tb03032.x"},{"key":"e_1_3_2_69_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40292-020-00396-9"},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1988.03720190031026"},{"key":"e_1_3_2_71_1","unstructured":"Glaxo-SmithKline (1998). Study AK1A1003. [data on file]. Glaxo-SmithKline."},{"key":"e_1_3_2_72_1","unstructured":"GlaxoSmithKline. (2009). FDA prescribing information for bupropion hydrochloride. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/018644s039s040.pdf"},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.34.8.1092"},{"key":"e_1_3_2_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0193-953X(18)30190-4"},{"key":"e_1_3_2_75_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2073"},{"key":"e_1_3_2_76_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1994.11"},{"issue":"3","key":"e_1_3_2_77_1","first-page":"CD000058","article-title":"Clonidine for smoking cessation","volume":"2004","author":"Gourlay S. G.","year":"2004","unstructured":"Gourlay, S. G., Stead, L. F., & Benowitz, N. L. (2004). Clonidine for smoking cessation. Cochrane Database of Systematic Reviews, 2004(3), CD000058.","journal-title":"Cochrane Database of Systematic Reviews,"},{"key":"e_1_3_2_78_1","first-page":"CD002024","article-title":"Alpha2-adrenergic agonists for the management of opioid withdrawal","volume":"3","author":"Gowing L.","year":"2014","unstructured":"Gowing, L., Farrell, M. F., Ali, R., & White, J. M. (2014). Alpha2-adrenergic agonists for the management of opioid withdrawal. The Cochrane Database of Systematic Reviews, 3, CD002024.","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"e_1_3_2_79_1","doi-asserted-by":"publisher","DOI":"10.18231\/j.ijohd.2019.017"},{"key":"e_1_3_2_80_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1988.tb03029.x"},{"key":"e_1_3_2_81_1","doi-asserted-by":"publisher","DOI":"10.3109\/00952990.2012.750665"},{"key":"e_1_3_2_82_1","first-page":"1","article-title":"Nortriptyline versus fluoxetine in the treatment of major depressive disorder: a six-month, double-blind clinical trial","volume":"4","author":"Hashemi S.","year":"2012","unstructured":"Hashemi, S., Shirazi, H. G., Mohammadi, A., Zadeh-Bagheri, G., Noorian, Kh., & Malekzadeh, M. (2012). Nortriptyline versus fluoxetine in the treatment of major depressive disorder: a six-month, double-blind clinical trial. ClinPharmacol, 4, 1\u20136.","journal-title":"ClinPharmacol,"},{"key":"e_1_3_2_83_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-006-0209-9"},{"key":"e_1_3_2_84_1","doi-asserted-by":"publisher","DOI":"10.1080\/146222003100073676"},{"key":"e_1_3_2_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2019.06.008"},{"key":"e_1_3_2_86_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000127"},{"key":"e_1_3_2_87_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2013.2"},{"key":"e_1_3_2_88_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1286287"},{"key":"e_1_3_2_89_1","doi-asserted-by":"publisher","DOI":"10.1177\/070674370905400604"},{"issue":"4","key":"e_1_3_2_90_1","first-page":"CD000031","article-title":"Antidepressants for smoking cessation","volume":"4","author":"Howes S.","year":"2020","unstructured":"Howes, S., Hartmann-Boyce, J., Livingstone-Banks, J., Hong, B., & Lindson, N. (2020). Antidepressants for smoking cessation. Cochrane Database Syst Rev, 4(4), CD000031.","journal-title":"Cochrane Database Syst Rev,"},{"key":"e_1_3_2_91_1","first-page":"CD000031","article-title":"Antidepressants for smoking cessation","volume":"1","author":"Hughes J. R.","year":"2007","unstructured":"Hughes, J. R., Stead, L. F., & Lancaster, T. (2007). Antidepressants for smoking cessation. The Cochrane Database of Systematic Reviews, 1, CD000031.","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"e_1_3_2_92_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.57.1.3"},{"key":"e_1_3_2_93_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199710233371703"},{"key":"e_1_3_2_94_1","doi-asserted-by":"publisher","DOI":"10.1586\/14737175.8.5.715"},{"key":"e_1_3_2_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2005.11.011"},{"key":"e_1_3_2_96_1","doi-asserted-by":"publisher","DOI":"10.1080\/17460441.2018.1458090"},{"key":"e_1_3_2_97_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.1.56"},{"key":"e_1_3_2_98_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-021-01789-0"},{"key":"e_1_3_2_99_1","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v63n0302"},{"key":"e_1_3_2_100_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199510000-00004"},{"key":"e_1_3_2_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/bs.podrm.2015.12.001"},{"key":"e_1_3_2_102_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2011.232"},{"key":"e_1_3_2_103_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0447.2001.00299.x"},{"key":"e_1_3_2_104_1","doi-asserted-by":"publisher","DOI":"10.2165\/11539240-000000000-00000"},{"key":"e_1_3_2_105_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.2018.302"},{"key":"e_1_3_2_106_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.b.30978"},{"key":"e_1_3_2_107_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41533-021-00259-3"},{"key":"e_1_3_2_108_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(01)21861-X"},{"key":"e_1_3_2_109_1","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.35.3.343"},{"key":"e_1_3_2_110_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11126-019-09689-2"},{"key":"e_1_3_2_111_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2017.0400"},{"key":"e_1_3_2_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuro.2006.05.019"},{"key":"e_1_3_2_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2020.03.014"},{"key":"e_1_3_2_114_1","doi-asserted-by":"publisher","DOI":"10.2165\/0003088-200948010-00005"},{"key":"e_1_3_2_115_1","doi-asserted-by":"publisher","DOI":"10.1080\/15504263.2017.1328149"},{"key":"e_1_3_2_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2010.01.016"},{"key":"e_1_3_2_117_1","doi-asserted-by":"publisher","DOI":"10.1017\/neu.2021.28"},{"key":"e_1_3_2_118_1","doi-asserted-by":"publisher","DOI":"10.4103\/ejgd.ejgd_100_19"},{"key":"e_1_3_2_119_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S46849"},{"key":"e_1_3_2_120_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1985.tb05743.x"},{"key":"e_1_3_2_121_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050047"},{"key":"e_1_3_2_122_1","doi-asserted-by":"publisher","DOI":"10.1002\/neu.10148"},{"key":"e_1_3_2_123_1","doi-asserted-by":"publisher","DOI":"10.18773\/austprescr.2015.038"},{"issue":"6","key":"e_1_3_2_124_1","first-page":"565","article-title":"Demethylation and hydroxylation of amitriptyline, nortriptyline, and 10-hydroxyamitriptyline in human liver microsomes","volume":"9","author":"Mellstr\u00f6m B.","year":"1981","unstructured":"Mellstr\u00f6m, B., & von Bahr, C. (1981). Demethylation and hydroxylation of amitriptyline, nortriptyline, and 10-hydroxyamitriptyline in human liver microsomes. Drug MetabDispos, 9(6), 565\u2013568.","journal-title":"Drug MetabDispos,"},{"key":"e_1_3_2_125_1","doi-asserted-by":"publisher","DOI":"10.1177\/1039856214562076"},{"key":"e_1_3_2_126_1","volume-title":"Nortriptyline","author":"Merwar G.","year":"2021","unstructured":"Merwar, G., Gibbons, J. R., Hosseini, S. A., & Saadabadi, A. (2021). Nortriptyline. StatPearls Publishing."},{"key":"e_1_3_2_127_1","first-page":"14","article-title":"Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation. A systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individuals","volume":"16","author":"Mills E. J.","year":"2018","unstructured":"Mills, E. J., Wu, P., Lockhart, I., Thorlund, K., Puhan, M., & Ebbert, J. O. (2018). Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation. A systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individuals. TobInduc Dis, 16, 14.","journal-title":"TobInduc Dis"},{"key":"e_1_3_2_128_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph10104790"},{"key":"e_1_3_2_129_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2001.113181"},{"issue":"4","key":"e_1_3_2_130_1","first-page":"CD004363","article-title":"Antidepressants for preventing postnatal depression","volume":"4","author":"Molyneaux E.","year":"2018","unstructured":"Molyneaux, E., Telesia, L. A., Henshaw, C., Boath, E., Bradley, E., & Howard, L. M. (2018). Antidepressants for preventing postnatal depression. Cochrane Database Syst Rev, 4(4), CD004363.","journal-title":"Cochrane Database Syst Rev,"},{"issue":"11","key":"e_1_3_2_131_1","first-page":"781","article-title":"ABC of smoking cessation. Nicotine replacement therapy","volume":"143","author":"Molyneux A.","year":"2004","unstructured":"Molyneux, A., Kr\u00e1l\u00edkov\u00e1, E., & Himmerov\u00e1, V. (2004). ABC of smoking cessation. Nicotine replacement therapy. CasLekCesk, 143(11), 781\u2013783.","journal-title":"CasLekCesk,"},{"key":"e_1_3_2_132_1","doi-asserted-by":"publisher","DOI":"10.1002\/pon.952"},{"key":"e_1_3_2_133_1","unstructured":"Network For Smoking E. & Prevention T. (2016). ENSP Guidelines for treating tobacco dependence the comprehensive guide to the implementation of treatments and strategies to treat tobacco dependence. https:\/\/elearning-ensp.eu\/assets\/English%2520version.pdf"},{"key":"e_1_3_2_134_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2008.01.016"},{"issue":"6","key":"e_1_3_2_135_1","first-page":"750","article-title":"In vivo induction and in vitro inhibition of hepatic cytochrome P450 activity by the benzodiazepine anticonvulsants clonazepam and diazepam","volume":"25","author":"Nims R. W.","year":"1997","unstructured":"Nims, R. W., Prough, R. A., Jones, C. R., Stockus, D. L., Dragnev, K. H., Thomas, P. E., & Lubet, R. A. (1997). In vivo induction and in vitro inhibition of hepatic cytochrome P450 activity by the benzodiazepine anticonvulsants clonazepam and diazepam. Drug Metabolism and Disposition: The Biological Fate of Chemicals, 25(6), 750\u2013756.","journal-title":"Drug Metabolism and Disposition: The Biological Fate of Chemicals"},{"key":"e_1_3_2_136_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199528010-00004"},{"issue":"6","key":"e_1_3_2_137_1","first-page":"740","article-title":"Hydroxylation and demethylation of the tricyclic antidepressant nortriptyline by cDNA-expressed human cytochrome P-450 isozymes","volume":"25","author":"Olesen O. V.","year":"1997","unstructured":"Olesen, O. V., & Linnet, K. (1997). Hydroxylation and demethylation of the tricyclic antidepressant nortriptyline by cDNA-expressed human cytochrome P-450 isozymes. Drug Metabolism and Disposition: The Biological Fate of Chemicals, 25(6), 740\u2013744.","journal-title":"Drug Metabolism and Disposition: The Biological Fate of Chemicals"},{"key":"e_1_3_2_138_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.107631"},{"key":"e_1_3_2_139_1","first-page":"121","article-title":"Metabolism and disposition of varenicline, a selective \u03b14 \u03b22 acetylcholine receptor partial agonist, in vivo and in vitro","volume":"34","author":"Orbach R. S.","year":"2006","unstructured":"Orbach, R. S., Reed-Hagen, A. E., & Krueger, S. S. (2006). Metabolism and disposition of varenicline, a selective \u03b14 \u03b22 acetylcholine receptor partial agonist, in vivo and in vitro. Drug MetabDispos, 34, 121\u2013130.","journal-title":"Drug MetabDispos,"},{"key":"e_1_3_2_140_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.148.9.2027"},{"key":"e_1_3_2_141_1","doi-asserted-by":"publisher","DOI":"10.1080\/15504263.2012.663675"},{"key":"e_1_3_2_142_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2021.1863948"},{"key":"e_1_3_2_143_1","unstructured":"Pfizer Labs. (n.d.). Chantix (varenicline) tablets: product information [online]. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/ 2009\/021928s012s013lbl.pdf"},{"key":"e_1_3_2_144_1","doi-asserted-by":"publisher","DOI":"10.5402\/2011\/805983"},{"key":"e_1_3_2_145_1","doi-asserted-by":"publisher","DOI":"10.1038\/34413"},{"key":"e_1_3_2_146_1","first-page":"263","article-title":"Antidepressants: past, present and future","volume":"157","author":"Preskorn S.","year":"2004","unstructured":"Preskorn, S., & Ross, R. (2004). Antidepressants: past, present and future. Other Antidepressants, 157, 263\u2013324.","journal-title":"Other Antidepressants,"},{"key":"e_1_3_2_147_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.152.10.2065"},{"key":"e_1_3_2_148_1","doi-asserted-by":"publisher","DOI":"10.1177\/1039856213486213"},{"key":"e_1_3_2_149_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.8.1177"},{"key":"e_1_3_2_150_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40596-017-0738-9"},{"key":"e_1_3_2_151_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.4.6.995"},{"key":"e_1_3_2_152_1","doi-asserted-by":"publisher","DOI":"10.1023\/a:1006949816036"},{"issue":"2","key":"e_1_3_2_153_1","first-page":"93","article-title":"A Study on CYP2C19 and CYP2D6 Polymorphic Effects on Pharmacokinetics and Pharmacodynamics of Amitriptyline in Healthy Koreans","volume":"10","author":"Ryu S.","year":"2017","unstructured":"Ryu, S., Park, S., Lee, J. H., Kim, Y. R., Na, H. S., Lim, H. S., Choi, H. Y., Hwang, I. Y., Lee, J. G., Park, Z. W., Oh, W. Y., Kim, J. M., & Choi, S. E. (2017). A Study on CYP2C19 and CYP2D6 Polymorphic Effects on Pharmacokinetics and Pharmacodynamics of Amitriptyline in Healthy Koreans. ClinTransl Sci, 10(2), 93\u2013101.","journal-title":"ClinTransl Sci,"},{"key":"e_1_3_2_154_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2009.09154.x"},{"key":"e_1_3_2_155_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881109351966"},{"key":"e_1_3_2_156_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.6b00189"},{"key":"e_1_3_2_157_1","doi-asserted-by":"publisher","DOI":"10.1007\/164_2018_167"},{"key":"e_1_3_2_158_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.2005.25.10.1378"},{"key":"e_1_3_2_159_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000146.pub2"},{"key":"e_1_3_2_160_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.47.120505.105354"},{"key":"e_1_3_2_161_1","first-page":"188","volume-title":"Hormone Analogues","author":"Sneader W.","year":"2006","unstructured":"Sneader, W. (2006). Hormone Analogues. Drug Discovery: JohnWiley&Sons. p.188\u2013225."},{"key":"e_1_3_2_162_1","first-page":"CD008286","article-title":"Combined pharmacotherapy and behavioural interventions for smoking cessation","volume":"3","author":"Stead L. F.","year":"2016","unstructured":"Stead, L. F., Koilpillai, P., Fanshawe, T. R., & Lancaster, T. (2016). Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev, 3, CD008286.","journal-title":"Cochrane Database Syst Rev,"},{"key":"e_1_3_2_163_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000146.pub3"},{"key":"e_1_3_2_164_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2004.041327"},{"key":"e_1_3_2_165_1","doi-asserted-by":"publisher","DOI":"10.15713\/ins.jmrps.117"},{"key":"e_1_3_2_166_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2020.106241"},{"key":"e_1_3_2_167_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1099420"},{"key":"e_1_3_2_168_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0014-2999(97)01393-9"},{"issue":"3","key":"e_1_3_2_169_1","first-page":"CD013522","article-title":"Smoking cessation for improving mental health","volume":"3","author":"Taylor G. M.","year":"2021","unstructured":"Taylor, G. M., Lindson, N., Farley, A., Leinberger-Jabari, A., Sawyer, K., Te Water Naud\u00e9, R., Theodoulou, A., King, N., Burke, C., & Aveyard, P. (2021). Smoking cessation for improving mental health. Cochrane Database Syst Rev, 3(3), CD013522.","journal-title":"Cochrane Database Syst Rev,"},{"key":"e_1_3_2_170_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g1151"},{"key":"e_1_3_2_171_1","unstructured":"The Royal Australian New Zealand College of Psychiatrists. (2022). Mental Health Clinician Guidance for Managing People\u2019s Smoking Cessation."},{"key":"e_1_3_2_172_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00414-007-0184-4"},{"key":"e_1_3_2_173_1","doi-asserted-by":"publisher","DOI":"10.3310\/hta25590"},{"key":"e_1_3_2_174_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13181-018-0685-1"},{"key":"e_1_3_2_175_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2020.1729708"},{"key":"e_1_3_2_176_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-004216"},{"key":"e_1_3_2_177_1","unstructured":"U.S. Department of Health and Human Services. (2020). Smoking Cessation. A report of the surgeon general. In: Atlanta GA: U.S. Department of Health and Human Services Centers for Disease Control and Prevention National Center for Chronic Disease Prevention and Health Promotion Office on Smoking and Health https:\/\/www.hhs.gov\/sites\/default\/files\/2020-cessation-sgr-full-report.pdf"},{"key":"e_1_3_2_178_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.108.057554"},{"key":"e_1_3_2_179_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2014.909405"},{"key":"e_1_3_2_180_1","doi-asserted-by":"publisher","DOI":"10.12816\/0048737"},{"key":"e_1_3_2_181_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2005.00998.x"},{"key":"e_1_3_2_182_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2018.12.064"},{"issue":"5","key":"e_1_3_2_183_1","first-page":"262","article-title":"Nonstimulant therapies for attention-deficit hyperactivity disorder (ADHD) in children and adults","volume":"6","author":"Waxmonsky J. G.","year":"2005","unstructured":"Waxmonsky, J. G. (2005). Nonstimulant therapies for attention-deficit hyperactivity disorder (ADHD) in children and adults. Essential Psychopharmacology, 6(5), 262\u2013276.","journal-title":"Essential Psychopharmacology"},{"key":"e_1_3_2_184_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.14208"},{"key":"e_1_3_2_185_1","unstructured":"WHO. (2019). WHO report on the global tobacco epidemic 2019: Offer help to quit tobacco use. World Health Organization"},{"key":"e_1_3_2_186_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.11m07522"},{"key":"e_1_3_2_187_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-6-300"},{"key":"e_1_3_2_188_1","doi-asserted-by":"publisher","DOI":"10.2147\/DHPS.S6299"},{"key":"e_1_3_2_189_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000547"},{"key":"e_1_3_2_190_1","doi-asserted-by":"publisher","DOI":"10.46747\/cfp.6710743"},{"key":"e_1_3_2_191_1","volume-title":"Clonidine.","author":"Yasaei R.","year":"2021","unstructured":"Yasaei, R., & Saadabadi, A. (2021). Clonidine. StatPearls Publishing."},{"key":"e_1_3_2_192_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2004.01.017"},{"key":"e_1_3_2_193_1","doi-asserted-by":"publisher","DOI":"10.1080\/14622200802443569"},{"key":"e_1_3_2_194_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1H310"}],"container-title":["International Review of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/09540261.2023.2249084","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T15:28:48Z","timestamp":1715182128000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/09540261.2023.2249084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,18]]},"references-count":193,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2023,8,18]]}},"alternative-id":["10.1080\/09540261.2023.2249084"],"URL":"https:\/\/doi.org\/10.1080\/09540261.2023.2249084","relation":{},"ISSN":["0954-0261","1369-1627"],"issn-type":[{"type":"print","value":"0954-0261"},{"type":"electronic","value":"1369-1627"}],"subject":[],"published":{"date-parts":[[2023,8,18]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iirp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iirp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-05-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}